Identification of acceptable HLA mismatches in immunized patients using single-antigen-expressing cell lines.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Tissue Antigens

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1399-0039.2007.00821.XPMID 17389021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extending options for highly sensitized patients to receive a suitable kidney graft.

  2005cited by this paper
• Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies.

  2005cited by this paper
• Single-Antigen-Expressing Cell Lines Are Excellent Tools for Detecting Human Leukocyte Antigen-C–Reactive Antibodies in Kidney Transplant Recipients

  2005cited by this paper
• The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.

  2005cited by this paper
• HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates

  2004cited by this paper
• The value of alloantibody detection in predicting response to HLA‐matched platelet transfusions

  2004cited by this paper
• Optimizing platelet transfusion therapy.

  2004cited by this paper
• It takes six to boogie: allocating cadaver kidneys in Eurotransplant.

  2004cited by this paper
• The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome.

  2004cited by this paper
• Best Abstracts

  2003cited by this paper
• Utility of Intravenous Immune Globulin in Kidney Transplantation: Efficacy, Safety, and Cost Implications

  2003cited by this paper
• Differential immunogenicity of paternal HLA Class I antigens in pregnant women.

  2003cited by this paper
• Desensitization and Subsequent Kidney Transplantation of Patients Using Intravenous Immunoglobulins (IVIg)

  2002cited by this paper
• Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match.

  2002cited by this paper
• The detection and relevance of pretransplant antibodies.

  1994cited by this paper
• Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.

  1989cited by this paper
• Reactivity of lymphocyte cytotoxic autoantibodies from renal patients with cell line K562.

  1984cited by this paper
• Significance of the positive crossmatch test in kidney transplantation.

  1969cited by this paper
• Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

  1966cited by this paper

• Understanding Human Leukocyte Antigens in Vascularized Composite Allotransplantation.

  2025cites this paper
• Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches

  2021cites this paper
• How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival

  2018cites this paper
• Transplantation in highly sensitized patients: challenges and recommendations

  2018cites this paper
• MARTINS HLA COMPLEX : BRIEF HISTORY , GENERAL CHARACTERIZATION AND IMPACT ON KIDNEY TRANSPLANTATION

  2016cites this paper
• Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations?

  2011cites this paper
• Defining unacceptable HLA antigens.

  2008cites this paper
• Role of anti-HLA antibodies in allograft rejection

  2007cites this paper